SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-20-269048
Filing Date
2020-10-14
Accepted
2020-10-14 08:58:12
Documents
3
Period of Report
2020-10-14
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d258347d8k.htm 8-K 17422
2 EX-99.1 d258347dex991.htm EX-99.1 12892
3 GRAPHIC g258347dsp01.jpg GRAPHIC 4080
  Complete submission text file 0001193125-20-269048.txt   37147
Mailing Address 7318 MORTON STREET DALLAS TX 75209
Business Address 7318 MORTON STREET DALLAS TX 75209 212.551.8702
Taysha Gene Therapies, Inc. (Filer) CIK: 0001806310 (see all company filings)

IRS No.: 843199512 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39536 | Film No.: 201238294
SIC: 2836 Biological Products, (No Diagnostic Substances)